» Articles » PMID: 25022876

Disclosure of Selective Advantages in the "modern" Sublineage of the Mycobacterium Tuberculosis Beijing Genotype Family by Quantitative Proteomics

Overview
Date 2014 Jul 16
PMID 25022876
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The Mycobacterium tuberculosis Beijing genotype, consisting of the more ancient (atypical) and modern (typical) emerging sublineage, is one of the most prevalent and genetically conserved genotype families and has often been associated with multidrug resistance. In this study, we employed a 2D-LC-FTICR MS approach, combined with dimethylation of tryptic peptides, to systematically compare protein abundance levels of ancient and modern Beijing strains and identify differences that could be associated with successful spread of the modern sublineage. The data is available via ProteomeXchange using the identifier PXD000931. Despite the highly uniform protein abundance ratios in both sublineages, we identified four proteins as differentially regulated between both sublineages, which could explain the apparent increased adaptation of the modern Beijing strains. These proteins are; Rv0450c/MmpL4, Rv1269c, Rv3137, and Rv3283/sseA. Transcriptional and functional analysis of these proteins in a large cohort of 29 Beijing strains showed that the mRNA levels of Rv0450c/MmpL4 are significantly higher in modern Beijing strains, whereas we also provide evidence that Rv3283/sseA is less abundant in the modern Beijing sublineage. Our findings provide a possible explanation for the increased virulence and success of the modern Beijing sublineage. In addition, in the established dataset of 1817 proteins, we demonstrate the pre-existence of several, possibly unique, antibiotic efflux pumps in the proteome of the Beijing strains. This may reflect an increased ability of Beijing strains to escape exposure to antituberculosis drugs.

Citing Articles

Genome-Wide Study of Drug Resistant and Its Intra-Host Evolution during Treatment.

Lagutkin D, Panova A, Vinokurov A, Gracheva A, Samoilova A, Vasilyeva I Microorganisms. 2022; 10(7).

PMID: 35889159 PMC: 9318467. DOI: 10.3390/microorganisms10071440.


Host-pathogen genetic interactions underlie tuberculosis susceptibility in genetically diverse mice.

Smith C, Baker R, Proulx M, Mishra B, Long J, Park S Elife. 2022; 11.

PMID: 35112666 PMC: 8846590. DOI: 10.7554/eLife.74419.


Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia.

Nieto Ramirez L, Ferro B, Diaz G, Anthony R, de Beer J, van Soolingen D PLoS One. 2020; 15(4):e0224908.

PMID: 32330146 PMC: 7182180. DOI: 10.1371/journal.pone.0224908.


Circulation of Beijing genotype in Latin America and the Caribbean.

Cerezo-Cortes M, Rodriguez-Castillo J, Hernandez-Pando R, Murcia M Pathog Glob Health. 2020; 113(8):336-351.

PMID: 31903874 PMC: 7006823. DOI: 10.1080/20477724.2019.1710066.


System OMICs analysis of Mycobacterium tuberculosis Beijing B0/W148 cluster.

Bespyatykh J, Shitikov E, Guliaev A, Smolyakov A, Klimina K, Veselovsky V Sci Rep. 2019; 9(1):19255.

PMID: 31848428 PMC: 6917788. DOI: 10.1038/s41598-019-55896-z.


References
1.
Geiger T, Cox J, Ostasiewicz P, Wisniewski J, Mann M . Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods. 2010; 7(5):383-5. DOI: 10.1038/nmeth.1446. View

2.
Bifani P, Mathema B, Kurepina N, Kreiswirth B . Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol. 2002; 10(1):45-52. DOI: 10.1016/s0966-842x(01)02277-6. View

3.
Cox J, Mann M . MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008; 26(12):1367-72. DOI: 10.1038/nbt.1511. View

4.
Cole S, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D . Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998; 393(6685):537-44. DOI: 10.1038/31159. View

5.
. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis. 2006; 12(5):736-43. PMC: 3374453. DOI: 10.3201/eid1205.050400. View